Reset all filters
01 4DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE)
02 15METHYLPHENIDATE HYDROCHLORIDE
03 4TIMOLOL (TIMOLOL MALEATE)
Reset all filters
01 7CAPSULE (CONTROLLED RELEASE)
02 8CAPSULE (EXTENDED RELEASE)
03 7SOLUTION
04 1SOLUTION (EXTENDED RELEASE)
Reset all filters
01 20.5%
02 1100MG
03 110MG
04 115MG
05 12%
06 12%/W/V
07 120MG
08 220MG/ML
09 125MG
10 130MG
11 135MG
12 140MG
13 145MG
14 150MG
15 155MG
16 25MG/ML
17 160MG
18 170MG
19 180MG
20 185MG
Reset all filters
01 8BIPHENTIN
02 2COSOPT
03 2COSOPT PRESERVATIVE-FREE
04 7FOQUEST
05 1TIMOPTIC
06 1TIMOPTIC-XE
07 1TRUSOPT
08 1TRUSOPT PRESERVATIVE-FREE
Regulatory Info : Prescription
Registration Country : Canada
DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE)
Dosage Form : SOLUTION
Dosage Strength : 2%
Packaging : 5ML
Brand Name : TRUSOPT
Approval Date :
Application Number : 2216205
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE)
Dosage Form : SOLUTION
Dosage Strength : 20MG/ML
Packaging : 10ML
Brand Name : COSOPT
Approval Date :
Application Number : 2240113
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE)
Dosage Form : SOLUTION
Dosage Strength : 20MG/ML
Packaging : 60X0.2ML
Brand Name : COSOPT PRESERVATIVE-FREE
Approval Date :
Application Number : 2258692
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE)
Dosage Form : SOLUTION
Dosage Strength : 2%/W/V
Packaging : 0.2ML
Brand Name : TRUSOPT PRESERVATIVE-FREE
Approval Date :
Application Number : 2269090
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Dosage Form : CAPSULE (CONTROLLED RELEASE)
Dosage Strength : 35MG
Packaging : 60
Brand Name : FOQUEST
Approval Date :
Application Number : 2470306
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Dosage Form : CAPSULE (CONTROLLED RELEASE)
Dosage Strength : 45MG
Packaging : 60
Brand Name : FOQUEST
Approval Date :
Application Number : 2470314
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Dosage Form : CAPSULE (CONTROLLED RELEASE)
Dosage Strength : 55MG
Packaging : 60
Brand Name : FOQUEST
Approval Date :
Application Number : 2470322
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Dosage Form : CAPSULE (CONTROLLED RELEASE)
Dosage Strength : 70MG
Packaging : 60
Brand Name : FOQUEST
Approval Date :
Application Number : 2470330
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Dosage Form : CAPSULE (CONTROLLED RELEASE)
Dosage Strength : 85MG
Packaging : 60
Brand Name : FOQUEST
Approval Date :
Application Number : 2470349
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada
Dosage Form : CAPSULE (CONTROLLED RELEASE)
Dosage Strength : 25MG
Packaging : 60
Brand Name : FOQUEST
Approval Date :
Application Number : 2470292
Regulatory Info : Schedule G (CDSA III)
Registration Country : Canada